Form 4: Director Carladenise Edwards Sells Clover Health Shares

Clover Health Investments, Corp. Director Carladenise Edwards sold 67,160 shares of Class A Common Stock on May 18, 2026.

Summary

• Director Carladenise Edwards disposed of 67,160 shares of Class A Common Stock.
• The shares were sold at a weighted average price of $3.42 per share.
• The transaction occurred on May 18, 2026.
• Following the sale, the director retains beneficial ownership of 285,432 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it is a routine disclosure of an insider transaction without accompanying negative operational news.

Positives

• The director maintains a significant remaining equity stake of 285,432 shares in the company.

Negatives

• The sale represents a reduction in the director's direct ownership position in the company.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in near-term share price appreciation.

Future Outlook

No forward-looking guidance or strategic outlook was provided in this filing.

Industry Context

StockSavvy.ai notes that director-level selling is a common occurrence for portfolio rebalancing or liquidity needs and does not necessarily reflect a change in the company's fundamental health or strategic direction.

Comparison to Industry Standards

• Insider transactions are standard regulatory disclosures for publicly traded companies.
• The scale of the sale relative to the director's total holdings is consistent with typical executive equity management practices.

Stakeholder Impact

• Shareholders should note the change in insider ownership levels.

Key Dates

Keywords

Clover Health, CLOV, Insider Trading, Form 4, Director Sale